{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:20:22Z","timestamp":1788931222561,"version":"build-2803163510"},"reference-count":8,"publisher":"Japan Surgical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surg Case Rep"],"published-print":{"date-parts":[[2025]]},"DOI":"10.70352\/scrj.cr.24-0044","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:20:58Z","timestamp":1738362058000},"page":"n\/a","source":"Crossref","is-referenced-by-count":3,"title":["Delayed Onset Immune-Related Pituitary Adrenal Insufficiency Induced by Neoadjuvant Nivolumab Therapy for Locally Advanced Lung Cancer in the Postoperative Period: A Case Report"],"prefix":"10.70352","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3148-9366","authenticated-orcid":false,"given":"Takafumi","family":"Kabuto","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinnosuke","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Terashita","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaito","family":"Kitahori","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ishikawa","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Japanese Red Cross Wakayama Medical Center, Wakayama, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"51119","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Forde PM, Spicer J, Lu S, et al. Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer. N Engl J Med 2022; 386: 1973\u201385.","DOI":"10.1056\/NEJMoa2202170"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Felip E, Altorki N, Zhou C, et al. Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial. Lancet 2021; 398: 1344\u201357.","DOI":"10.1016\/S0140-6736(21)02098-5"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wakelee H, Liberman M, Kato T, et al. Perioperative pembrolizumab for early-stage non-small-cell lung cancer. N Engl J Med 2023; 389: 491\u2013503.","DOI":"10.1056\/NEJMoa2302983"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Barroso-Sousa R, Barry WT, Garrido-Castro AC, et al. Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis. JAMA Oncol 2018; 4: 173\u201382.","DOI":"10.1001\/jamaoncol.2017.3064"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kobayashi T, Iwama S, Yasuda Y, et al. Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: a prospective study. J Immunother Cancer 2020; 8: e000779.","DOI":"10.1136\/jitc-2020-000779"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Brahmer JR, Abu-Sbeih H, Ascierto PA, et al. Society for immunotherapy of cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events. J Immunother Cancer 2021; 9: e002435.","DOI":"10.1136\/jitc-2021-002435"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Garrahy I, Nicholas P 3rd, Oladiran O, et al. Takotsubo cardiomyopathy secondary to adrenal insufficiency: a case report and literature review. Case Rep Cardiol 2020; 2020: 6876951.","DOI":"10.1155\/2020\/6876951"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Otsubo K, Nakatomi K, Furukawa R, et al. Two cases of late-onset secondary adrenal insufficiency after discontinuation of nivolumab. Ann Oncol 2017; 28: 3106\u20133107.","DOI":"10.1093\/annonc\/mdx497"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.24-0044\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:19:52Z","timestamp":1738387192000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/scrj\/11\/1\/11_cr.24-0044\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.70352\/scrj.cr.24-0044","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"cr.24-0044"}}